Gyre TherapeuticsGYRE
13F holders, Q2 2024 (June 30)30holders +9
15new positions
7sold out
1famous investor
$11.93avg. 13F price*
At the end of Q2 2024, 30 institutions reported holding Gyre Therapeutics Inc. (GYRE) in their 13F filings, up 9 from Q1 2024. 15 opened new positions and 7 sold out. The largest holders were BlackRock Inc. ($6.0M), Geode Capital Management, LLC ($3.1M) and Vanguard Group Inc. ($2.8M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Gyre Therapeutics Inc.
- CUSIP
- 403783103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $1.3M |
| Exits | 7 | $2.7M |
All 13F filers, Q1 2024 → Q2 2024: 640,062 shares bought and 202,906 shares sold, net +437,156 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| BlackRock Inc. | 0.00% | Add +190.7% | 499,489 | $6.0M |
| Geode Capital Management, LLC | 0.00% | Add +61.8% | 259,807 | $3.1M |
| Vanguard Group Inc. | 0.00% | Add +18.7% | 231,641 | $2.8M |
| State Street Corp. | 0.00% | Add +137.0% | 96,078 | $1.1M |
| Northern Trust Corp. | 0.00% | Add +35.9% | 32,700 | $390K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 23,091 | $275K |
| WINTON GROUP Ltd | 0.01% | New | 18,467 | $220K |
| Bank of New York Mellon Corp | 0.00% | New | 18,266 | $218K |
| Renaissance Technologies | 0.00% | New | 13,900 | $166K |
| Marshall Wace, LLP | 0.00% | Reduce -58.0% | 10,720 | $128K |
| Rhumbline Advisers | 0.00% | New | 10,291 | $123K |
| New York State Common Retirement Fund | 0.00% | New | 10,200 | $122K |
| Morgan Stanley | 0.00% | Add +27.5% | 7,273 | $87K |
| Bank of America Corp. | 0.00% | New | 4,969 | $59K |
| Corebridge Financial, Inc. | 0.00% | — | 3,752 | $45K |
| Wells Fargo & Company | 0.00% | Add +3011.5% | 2,987 | $36K |
| JPMorgan Chase & Co. | 0.00% | Reduce -85.2% | 2,975 | $35K |
| Barclays PLC | 0.00% | New | 2,433 | $29K |
| UBS Group AG | 0.00% | New | 2,123 | $25K |
| Citigroup Inc. | 0.00% | Reduce -87.2% | 1,562 | $19K |
| Royal Bank of Canada | 0.00% | New | 1,052 | $13K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 683 | $8K |
| Osaic Holdings, Inc. | 0.00% | Add +4478.6% | 641 | $8K |
| Legal & General Group Plc | 0.00% | New | 603 | $7K |
| Activest Wealth Management | 0.00% | New | 533 | $6K |
| BNP Paribas Financial Markets | 0.00% | Reduce -27.6% | 520 | $6K |
| California State Teachers Retirement System | 0.00% | New | 505 | $6K |
| Amalgamated Bank | 0.00% | New | 241 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -91.3% | 249 | $3K |
| Acadian Asset Management LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is GYRE's weight in each manager's 13F, not the share of Gyre Therapeutics Inc. the manager owns.